SP

Saraswathi Punugoti

Director DIN 01974132
DIN 01974132 First appointment Oct 2000
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2000
Shareholding value β€’β€’β€’β€’ Premium profile

About Saraswathi Punugoti

Data last updated:

Saraswathi Punugoti was a Director at Golden Bricks Builders And Developers Private Limited (from 2008) and Director at Biogen Bio-Technologies Limited (from 2000).

DIN 01974132
First Appointment 09 Oct 2000
Oldest Company Age 26 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jan 20082006Strike Off
Biogen Bio-Technologies Limited U24230TG2000PLC035425
Director09 Oct 20002000Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Golden Bricks Builders And Developers Private Limited
Biogen Bio-Technologies Limited
Premium access

Shareholding and investment profile for Saraswathi Punugoti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saraswathi Punugoti

Saraswathi Punugoti was first appointed on 09 Oct 2000 as Director at Biogen Bio-Technologies Limited. The most recent appointment on record is 24 Jan 2008 at Golden Bricks Builders And Developers Private Limited.

Saraswathi Punugoti held 2 earlier board appointments: Golden Bricks Builders And Developers Private Limited (Director, from 24 Jan 2008); Biogen Bio-Technologies Limited (Director, from 09 Oct 2000).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available